⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Official Title: A Randomised, Open-label Trial of a Multimodal Intervention (Exercise, Nutrition and Antiinflammatory Medication) Plus Standard Care Versus Standard Care Alone to Prevent/Attenuate Cachexia in Advanced Cancer Patients Undergoing Chemotherapy

Study ID: NCT02330926

Study Description

Brief Summary: Cancer cachexia is a multi-factorial syndrome defined by an ongoing loss of skeletal muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment. There is an urgency for improving management, but there is no consensus on the optimal treatment for cancer cachexia. Several single therapies for cancer cachexia have been examined in clinical trials, with disappointing overall results. As multiple factors are responsible for the development of cachexia, it has been argued that optimal cachexia interventions should target all components: multimodal therapy for a multimodal problem. The overall aim of this study is to early prevent the development of cachexia rather than treatment late in the disease trajectory. From a patient perspective a short term effect will be to improve physical and psychological function, to reduce symptom burden and to improve survival. In other words live a longer and better life during and after chemotherapy. Direct effects of the cachexia intervention are expected to be reduction of weight and muscle loss, and improved physical activity and quality of life.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cedars-Sinai Medical Center, Los Angeles, California, United States

CA4 Brampton Civic Hospital, Brampton, , Canada

Cross Cancer Insitute, Edmonton, , Canada

Jewish General Hospital, Montréal, , Canada

Ottawa Regional Cancer Centre, Ottawa, , Canada

Universitätsklinikum Bonn, Bonn, , Germany

Oslo University Hospital, Oslo, , Norway

St Olavs Hospital, Trondheim, , Norway

Tumor Zentrum, Aarau, , Switzerland

Cantonal Hospital, St. Gallen, , Switzerland

NHS Forth Valley, Larbert, Falkirk, United Kingdom

Queen Margaret Hospital, Dunfermline, Fife, United Kingdom

Llandough Hospital, Cardiff, , United Kingdom

Edinburgh Cancer Centre, Edinburgh, , United Kingdom

Beatson West of Scotland Cancer Centre, Glasgow, , United Kingdom

Chelsea and Westminister Hospital NHS, London, , United Kingdom

Guys and St Thomas, London, , United Kingdom

Contact Details

Name: Stein Kaasa, MD PhD

Affiliation: European Palliative Care Research Centre (PRC), Department of Cancer Research and Molecular Medicine, Faculty of Medicine, NTNU, Trondheim, Norway

Role: STUDY_DIRECTOR

Name: Marie Fallon, MD PhD

Affiliation: Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: